Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer
| 대상 질환 | Lung Cancer |
|---|---|
| 임상 단계 | 단계 해당 없음 |
| 스폰서 | Massachusetts General Hospital |
| 상태 | 완료 |
| 참여자 수 | 507 명 |
| 중재(약물) | Stepped PC, Early Integrated PC |
| 시작일 | 2018년 2월 1일 |
| 완료일 | 2023년 7월 1일 |
| 결과 공개일 | 2024년 9월 3일 |
요약
This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer
Patient-reported Quality of Life
| Stepped PC | 100.62 score on a scale |
|---|---|
| Early Integrated PC | 97.75 score on a scale |
| p-value | <0.05 |
|---|---|
| Mean Difference (Final Values) | 2.9 |
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer — M.D. Anderson Cancer Center
- Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tum — National Cancer Institute (NCI)
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients W — National Cancer Institute (NCI)
- A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients W — AstraZeneca
- Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therap — National Cancer Institute (NCI)
- Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With — National Cancer Institute (NCI)